Witold Tłustochowicz

1.2k total citations
85 papers, 538 citations indexed

About

Witold Tłustochowicz is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Witold Tłustochowicz has authored 85 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 14 papers in Pathology and Forensic Medicine and 12 papers in Immunology. Recurrent topics in Witold Tłustochowicz's work include Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (19 papers) and Systemic Sclerosis and Related Diseases (10 papers). Witold Tłustochowicz is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (19 papers) and Systemic Sclerosis and Related Diseases (10 papers). Witold Tłustochowicz collaborates with scholars based in Poland, United States and Argentina. Witold Tłustochowicz's co-authors include Bartłomiej Kisiel, Artur Bachta, Małgorzata Tłustochowicz, Rafał Płoski, C.L. Benhamou, Robert R. Recker, Rachelle Eusebio, Piotr Wiland, A. Widmer and Z. Man and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Witold Tłustochowicz

71 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Witold Tłustochowicz Poland 12 226 146 101 89 80 85 538
Angelo Zoli Italy 15 275 1.2× 130 0.9× 35 0.3× 67 0.8× 56 0.7× 29 588
Ricardo Manoel de Oliveira Brazil 15 222 1.0× 220 1.5× 61 0.6× 40 0.4× 36 0.5× 26 661
Bevra Hahn United States 10 195 0.9× 149 1.0× 81 0.8× 33 0.4× 69 0.9× 21 523
Joaquim Polido‐Pereira Portugal 15 393 1.7× 222 1.5× 50 0.5× 126 1.4× 67 0.8× 54 730
Camille P. Figueiredo Brazil 19 354 1.6× 139 1.0× 263 2.6× 88 1.0× 71 0.9× 48 860
Béatrice Pallot-Pradès France 12 334 1.5× 163 1.1× 136 1.3× 75 0.8× 61 0.8× 24 594
Jinju Nishino Japan 15 540 2.4× 84 0.6× 84 0.8× 129 1.4× 144 1.8× 46 851
Cinzia Rotondo Italy 13 151 0.7× 73 0.5× 61 0.6× 37 0.4× 56 0.7× 43 473
Nuh Ataş Türkiye 14 169 0.7× 198 1.4× 40 0.4× 102 1.1× 87 1.1× 43 573
Gianantonio Saviola Italy 15 267 1.2× 97 0.7× 68 0.7× 45 0.5× 94 1.2× 42 466

Countries citing papers authored by Witold Tłustochowicz

Since Specialization
Citations

This map shows the geographic impact of Witold Tłustochowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Witold Tłustochowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Witold Tłustochowicz more than expected).

Fields of papers citing papers by Witold Tłustochowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Witold Tłustochowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Witold Tłustochowicz. The network helps show where Witold Tłustochowicz may publish in the future.

Co-authorship network of co-authors of Witold Tłustochowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Witold Tłustochowicz. A scholar is included among the top collaborators of Witold Tłustochowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Witold Tłustochowicz. Witold Tłustochowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bachta, Artur, et al.. (2023). Uveitis in rheumatic diseases — therapeutic management. 9(3). 112–118.
3.
Tłustochowicz, Małgorzata, Bartłomiej Kisiel, & Witold Tłustochowicz. (2019). Quality of life and clinical outcomes in Polish patients with high activity rheumatoid arthritis treated with leflunomide (Arava®) in Therapeutic Program: A retrospective analysis of data from the PLUS study. Advances in Clinical and Experimental Medicine. 28(11). 1545–1553. 4 indexed citations
4.
Kisiel, Bartłomiej, Artur Bachta, Kajetan Klos, et al.. (2018). Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration. Rheumatology International. 39(2). 327–336. 8 indexed citations
5.
Tłustochowicz, Witold, et al.. (2016). Witamina D w reumatoidalnym zapaleniu stawów. Postępy Nauk Medycznych.
6.
Marcinowska-Suchowierska, Ewa, Piotr Głuszko, J Badurski, et al.. (2015). Treatment of osteoporosis in Poland – availability and reasons for lack of implementation. Postępy Nauk Medycznych. 2 indexed citations
7.
Bachta, Artur, et al.. (2012). Glucocorticoid-induced osteoporosis. Postępy Nauk Medycznych. 23 indexed citations
8.
Dębski, Romuald, et al.. (2011). Zespół HELLP u chorej na toczeń rumieniowaty układowy i wtórny zespół antyfosfolipidowy. SHILAP Revista de lepidopterología.
9.
Tłustochowicz, Witold, et al.. (2011). Częstość występowania i związek poznanych mutacji w genach HFE z fenotypami wybranych chorób reumatycznych. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Tłustochowicz, Witold, et al.. (2011). „Długoterminowa ocena bezpieczeństwa i skuteczności leczenia biologicznego młodzieńczego idiopatycznego zapalenia stawów” – prezentacja polskiego rejestru elektronicznego. SHILAP Revista de lepidopterología.
11.
Tłustochowicz, Witold. (2011). Postępy w diagnostyce i terapii chorób reumatycznych. Przewodnik Lekarza/Guide for GPs. 14(1). 94–101. 1 indexed citations
12.
Tłustochowicz, Witold, et al.. (2011). Prevalence of anti-thyroid antibodies and thyroid dysfunction in selected rheumatic diseases. Reumatologia/Rheumatology. 49(2). 132–137. 1 indexed citations
13.
Żuber, Zbigniew, et al.. (2011). “Long-term assessment of safety and efficacy of biological treatment in juvenile idiopathic arthritis” – the register of Polish patients. Reumatologia/Rheumatology. 49(1). 10–15.
14.
Tłustochowicz, Witold, et al.. (2011). Hemorrhagic colitis as a complication of treatment with cyclophosphamide. Reumatologia/Rheumatology. 49(4). 275–278. 2 indexed citations
15.
Śliwczyński, Andrzej, et al.. (2010). Financial aspects of biological treatment of rheumatoid and juvenile idiopathic arthritis patients participating in therapeutic programmes of NFZ in years 2004-2008. Reumatologia/Rheumatology. 48(1). 14–24.
16.
Rutkowska‐Sak, Lidia, et al.. (2009). Standards of treatment of the National Consultant for Rheumatology standpoint for the biologic therapy of juvenile idiopathic arthritis. Reumatologia/Rheumatology. 47(3). 111–115. 1 indexed citations
17.
Tłustochowicz, Witold, Marek Brzosko, Anna Filipowicz‐Sosnowska, et al.. (2008). STANDARDS OF TREATMENT Position of the Expert Panel of the National Consultant for Rheumatology concerning diagnosis and treatment of rheumatoid arthritis. Reumatologia/Rheumatology. 46(3). 111–114. 1 indexed citations
18.
Delmas, Pierre D., C.L. Benhamou, Z. Man, et al.. (2007). Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. Osteoporosis International. 19(7). 1039–1045. 48 indexed citations
19.
Tłustochowicz, Witold, et al.. (2005). ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Ultrasonography, magnetic resonance imaging and conventional radiography of bone erosions in rheumatoid arthritis – a comparative study. Reumatologia/Rheumatology. 43(6). 301–309. 3 indexed citations
20.
Urbanek, R., et al.. (2000). [Incidence of osteoporosis in patients with rheumatoid arthritis].. PubMed. 57(2). 103–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026